How does COVID-19 affect prostate cancer?

Published Date: 14 Mar 2023

As the COVID-19 pandemic spreads, access to and delivery of health services has been disrupted like never before. How has it affected the treatment of prostate cancer?

Read Full News

Latest News

A Man With Severe Gallbladder Dyskinesia

Severe gallbladder dysfunction may present without stones: a case of EF 2% on HIDA in a patient with fatty-meal pain whose pathology showed mild chronic cholecystitis.

Early PsA Detection: Biomarkers and Genetics

Dr Vinod Chandran discusses biomarkers, genetics, and clinical features that assess risk for psoriatic arthritis.

Precision Nutrition for Better Clinical Outcomes

Precision nutrition integrates genetics, the gut microbiome, metabolomics and lifestyle data to tailor dietary therapy promising better clinical outcomes.

When to Operate on a Pancreatic Cyst

More incidental pancreatic cysts are being found with modern imaging; physicians must weigh MRI surveillance against high risk surgery based on size, growth, and duct dilation.

S3 Episode 2: Endometrial Cancer Research: The Past, Present, and Future

Drs Ursula A. Matulonis and David G. Mutch discuss past and present endometrial cancer research, including the Route 66 SPORE.

S3 Episode 1: Phase 3 Trial ADCs in Endometrial Cancer

Drs Ursula Matulonis and Brian Slomovitz discuss phase 3 trials of ADCs in endometrial cancer and what's to come in the field of endometrial cancer therapeutics.

Todays Updates

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

Researchers evaluate whether postoperative ctDNA-guided adjuvant atezolizumab after radical cystectomy is cost-effective compared with standard care in patients with muscle-invasive bladder cancer.

PSA Often Unchanged With Enzalutamide Progression

A stable PSA level does not rule out progression in men taking enzalutamide for advanced prostate cancer.

Todays Updates

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

Researchers evaluate whether postoperative ctDNA-guided adjuvant atezolizumab after radical cystectomy is cost-effective compared with standard care in patients with muscle-invasive bladder cancer.

PSA Often Unchanged With Enzalutamide Progression

A stable PSA level does not rule out progression in men taking enzalutamide for advanced prostate cancer.

Latest News

Severe gallbladder dysfunction may present without stones: a case of EF 2% on HIDA in a patient with fatty-meal pain whose pathology showed mild chronic cholecystitis.

Dr Vinod Chandran discusses biomarkers, genetics, and clinical features that assess risk for psoriatic arthritis.

Precision nutrition integrates genetics, the gut microbiome, metabolomics and lifestyle data to tailor dietary therapy promising better clinical outcomes.

More incidental pancreatic cysts are being found with modern imaging; physicians must weigh MRI surveillance against high risk surgery based on size, growth, and duct dilation.

Drs Ursula A. Matulonis and David G. Mutch discuss past and present endometrial cancer research, including the Route 66 SPORE.

Drs Ursula Matulonis and Brian Slomovitz discuss phase 3 trials of ADCs in endometrial cancer and what's to come in the field of endometrial cancer therapeutics.

News All Time

Mar 20 2026 This Week in Cardiology

Listener feedback, the huge CLOSURE-AF trial of LAAC vs best medical therapy, previews of CHAMPION AF, and the controversial ACC/AHA lipid treatment guidelines are the topics John Mandrola, MD, discusses in this week's podcast.

Insights in Renal Cell Carcinoma From ASCO GU 2026

Clinically significant developments in RCC presented at ASCO GU, including insights into the growing importance of HIF-2α inhibition, are discussed by Dr Brian Rini of Vanderbilt University.

Quantifying Cardiac Amyloid Burden

A standardized metric to quantify amyloid burden has yet to be established. Could extracellular volume assessments help track ATTR-CM disease status.

A 2-Year-Old Girl With a Single Pink “Bump” on Her Abdomen

The bump had been present for about 3 months. The patient’s mother said there had been no bleeding, tenderness, color change, rapid growth, or preceding trauma.

Rules for Thee, Not for Me: Neuroscience & Double Standards

With respect to the so-called ‘moral compass’, humans invariably judge others more harshly than they judge themselves.

ACC 2026: Anticipating New Data in Amyloid and ATTR-CM

Dr Kevin M. Alexander prepares for updates on amyloid research, real-world evidence, and imaging biomarkers.

What the 'Relax Your Tight End' Super Bowl Ad Got Wrong

PSA tests are never 'simple.' Dr Kenny Lin discusses how to move beyond overdiagnosis toward truly informed prostate cancer screening.

EoE on the Rise: What Every Endoscopist Should Know

Dr David Johnson highlights the recommendations most likely to change how you endoscopically manage this increasingly prevalent disease.

Staying the Course After EGFR Progression

Dr Mark Kris highlights a recent study on osimertinib in NSCLC and outlines the best approaches for treatment beyond progression.

When Patients Feel Unheard: The Communication Gap in Care

Dr Mark Lewis discusses a recent social-media post which led to a reflection on how physicians can actively listen to patients and facilitate shared decision making.

Gastric Cancer: Focused Screening, Better Outcomes

Early detection saves lives in gastric cancer, but in Western settings the key lies in risk stratification, Helicobacter pylori eradication, and high-quality endoscopy.

AI in Medicine Desperately Needs Less Hype and More Honesty

A Yale School of Medicine professor argues that total transparency is the only way AI can become a trustworthy tool for physicians and patients.

Tethered to Tech, Nurses Suffer Digital Compassion Fatigue

The explosion of telehealth, remote monitoring, and screen-based charting is leading to digital compassion fatigue for nurses.

When Saying Less Helps in Primary Care Consultations

According to experts, primary care physicians may improve listening and therapeutic relationships by deliberately using silence during consultations.

What Happened to the Prestige of Being a Doctor?

‘Back in the day’ butts heads with ‘medicine today.’ A candid look at why physicians may never have the authority, respect, and trust doctors enjoyed 50 years ago.

Recommended News For You

Researchers have determined that malignancy hibernation will be the next front in the fight against breast cancer.

Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity

In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.

Additional imaging techniques can detect early stage cancers missed by mammograms in women with dense breasts

We Don't Always Know What's 'Best' for Our Patients

I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.

Early palliative care billing up from 2010 to 2019 for advanced cancer

Recommended Articles For You

Unpacking Chordoma: Understanding the Rare Cancer and its Treatment Options  

Protein S-Palmitoylation in Cancer: A Novel Target in Immunotherapy & Treatment 

Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy 

Unlocking the Secrets of Follicular Cells: Exploring the Potential of Stem Cell Research 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Alkem introduces cetuximab under the trade name Cetuxa in India.

2.

New protocols, according to a study, allow many patients to safely return home one day after lung cancer surgery.

3.

Sustained reduction found in prostate cancer mortality with prostate-specific antigen screening

4.

Hybrid imaging test combines antibody and radioisotope for early lung cancer detection

5.

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona

1.

Unlocking the Potential of Ferrotonia: A New Way to Harness Magnetic Energy

2.

Everything You Need To Know About Trichelemmal Cysts: Symptoms, Causes, Diagnosis And Treatment

3.

A Visual Guide to Understanding Breast Cancer Staging

4.

CAR-T Cell Therapy for Diffuse Large B-Cell Lymphoma: A Comprehensive Review

5.

Getting to Know RDW and SD: How They Relate to Anemia, Inflammation, and More 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

2.

Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC

3.

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

4.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

5.

Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot